Skip to main content
CVR Medical Corp. logo

CVR Medical Corp. — Investor Relations & Filings

Ticker · CRRVF ISIN · CA1266321084 LEI · 529900OWDQVO6GEB1G69 TSXV Professional, scientific and technical activities
Filings indexed 70 across all filing types
Latest filing 2022-12-20 Capital/Financing Update
Country CA Canada
Listing TSXV CRRVF

About CVR Medical Corp.

http://cvrmed.com/

CVR Medical Corp. is a med-tech organization dedicated to the research, development, and commercialization of disruptive diagnostic technology utilizing subsonic, infrasonic, and low frequency sound wave analysis. The company's core product is the Carotid Stenotic Scan (CSS), a non-invasive diagnostic tool engineered to assess Carotid Arterial health. The CSS functions by detecting and quantifying the degree of carotid narrowing (stenosis) to identify individuals at risk for Ischemic Stroke. This technology addresses the critical need for effective screening of Carotid Artery Disease (CAD) by offering a novel assessment method intended to improve clinical outcomes for patients, healthcare providers, and payors.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing an amended restructuring agreement between CVR Medical Corp. and CVR Global Inc. It details changes in licensing terms, share release schedules, liabilities assumed, and future plans for the company's medical device. There is no presentation of financial statements, quarterly or annual results, or detailed financial analysis. The document focuses on corporate restructuring and capital-related agreements, specifically share releases and licensing royalties. It is not a full financial report, earnings release, or management discussion. The content fits best under Capital/Financing Update (CAP) as it relates to restructuring agreements and share release schedules impacting the company's capital structure.
2022-12-20 English
News release - English.pdf
Report Publication Announcement Classification · 95% confidence The document is a press release announcing the completion and filing of the 2022 third quarter financial statement by CVR Medical Corp. It states that the financial report is posted on SEDAR but does not contain the actual financial statements or substantive financial data itself. The document length is 4460 characters, which is relatively short and mainly serves as an announcement rather than the report itself. According to the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2022-12-02 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification form titled 'Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate' signed by the CFO of CVR Medical Corp. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2022. The document explicitly states it is a certification related to interim filings, not the filings themselves. It contains no actual financial data or detailed financial statements, only a certification of their accuracy and completeness. The document length is short (3032 characters), and it serves as an officer certification rather than the interim report itself. According to the CERTIFICATION RULE, such documents should be classified as Regulatory Filings (RNS), not as the interim report (IR).
2022-12-02 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CEO of CVR Medical Corp. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2022. The content is primarily an officer certification letter related to interim filings, not the interim report itself. It does not contain substantive financial data or analysis but is a regulatory attestation. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS), not as the interim report (IR). The document length is short (2971 characters), consistent with a certification letter rather than a full report.
2022-12-02 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Management Discussion and Analysis for CVR Medical Corp. for the nine months ended September 30, 2022' and is prepared as of November 30, 2022. It contains detailed discussion of the company's financial position, results of operations, business overview, clinical trials, regulatory status, and forward-looking statements. It references condensed interim consolidated financial statements for the nine months ended September 30, 2022, indicating it is an interim report covering a period shorter than a full fiscal year. The document is substantive and contains financial data and analysis, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-12-02 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Consolidated Financial Statements Nine Months Ended September 30, 2022 (Unaudited)' and contains detailed financial statements including statements of financial position, comprehensive loss, changes in equity, and cash flows for the nine months ended September 30, 2022. It also includes extensive notes on corporate information, basis of presentation, going concern, and critical accounting judgments. The document explicitly states it is prepared in accordance with IFRS IAS 34 Interim Financial Reporting, which is the standard for interim financial statements. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a full interim report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2022-12-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.